Cargando…
Ketamine and Ro 25-6981 Reverse Behavioral Abnormalities in Rats Subjected to Dietary Zinc Restriction
Clinical and preclinical studies indicate that zinc (Zn) is an essential factor in the development and treatment of major depressive disorder (MDD). Conventional monoamine-based antidepressants mobilize zinc in the blood and brain of depressed patients as well as rodents. N-methyl-D-aspartate acid r...
Autores principales: | Pochwat, Bartłomiej, Domin, Helena, Rafało-Ulińska, Anna, Szewczyk, Bernadeta, Nowak, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369754/ https://www.ncbi.nlm.nih.gov/pubmed/32640759 http://dx.doi.org/10.3390/ijms21134791 |
Ejemplares similares
-
Zinc Deficiency Blunts the Effectiveness of Antidepressants in the Olfactory Bulbectomy Model of Depression in Rats
por: Rafało-Ulińska, Anna, et al.
Publicado: (2022) -
NMDA receptor antagonists ketamine and Ro25-6981 inhibit evoked release of glutamate in vivo in the subiculum
por: Stan, T L, et al.
Publicado: (2014) -
Relationship between Zinc (Zn(2+)) and Glutamate Receptors in the Processes Underlying Neurodegeneration
por: Pochwat, Bartłomiej, et al.
Publicado: (2015) -
Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study
por: Pascual-Antón, Raquel, et al.
Publicado: (2021) -
Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice
por: Pochwat, Bartłomiej, et al.
Publicado: (2018)